Physician profile
William R Bies
NPI 1760414510
$4,383.91
in general payments reported to CMS, 2019-2025
16 companies · $664 in 2025
The $664 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $566 · 2023: $1,186 · 2024: $1,765 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,270 · Education: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,270.45 |
| Education | $344.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,002.36 | 2022-2025 | |
| Janssen Biotech, INC. | $997.86 | 2021-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $505.32 | 2022-2024 | Ilumya, Odomzo |
| E.R. Squibb & Sons, L.L.C. | $418.09 | 2023-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $320.13 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $255.63 | 2022-2025 | Libtayo, Dupixent |
| Amgen INC. | $222.02 | 2022-2024 | Otezla |
| Organon LLC | $200.28 | 2023-2025 | Hadlima |
| Genzyme Corporation | $134.25 | 2024-2025 | |
| Dermavant Sciences, INC. | $125.49 | 2023-2024 | Vtama |
| Ucb, INC. | $104.30 | 2022-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $36.55 | 2023 | |
| Incyte Corporation | $26.51 | 2023 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.86 | 2022 | |
| Leo Pharma INC. | $12.17 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $9.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.